ARTICLE | Company News
InterMune, MoliChem terminate CF deal
December 27, 2002 8:00 AM UTC
ITMN and MLCM terminated their 2001 a development and commercialization deal for MLCM's Moli1901 to treat cystic fibrosis (CF). As a result, MLCM reacquired all rights to the compound and will not rec...